TrialCancer immunology, immunotherapy : CII2019

A phase II study of the L19IL2 immunocytokine in combination with dacarbazine in advanced metastatic melanoma patients.

Benjamin Weide et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.